Oxford BioMedica PLC

Research Oxford BioMedica PLC (OXB) on Bullrun: market cap GBX 74.10B. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerOXB
• ExchangeLSE
• CountryUnited Kingdom
• SectorHealthcare
• IndustryBiotechnology
• CurrencyGBX
• Market capGBX 74.10B
• Financial periodFY2025
• RevenueGBP 168.74M
• Revenue growth31.0%
• Net income-GBP 30.13M
• Free cash flow-GBP 4.25M
• Gross margin39.1%

Valuation Snapshot

latest market cap is GBX 74.10B.

About Oxford BioMedica PLC

Oxford Biomedica plc, a contract development and manufacturing organization, focuses on delivering therapies to patients worldwide. Its LentiVector platform technology is a lentiviral vector based gene delivery system which is designed to overcome the safety and delivery problems associated with earlier generations of vector systems; InAAVate, a proprietary ‘plug and play' dual-plasmid system for transient transfection, as well as a standard triple transfection system for AAV-based gene therapies.

Frequently asked questions

What is Oxford BioMedica PLC's market cap?

Oxford BioMedica PLC's market capitalization is GBX 74.10B.

What does Oxford BioMedica PLC do?

Oxford Biomedica plc, a contract development and manufacturing organization, focuses on delivering therapies to patients worldwide.